Biomarkers are measurable indicators of a biological state or condition, often used in cancer for diagnosis, prognosis, and monitoring response to treatment. Molecular alterations can serve as biomarkers. For example, the presence of the BRCA1 or BRCA2 mutations indicates a higher risk of breast and ovarian cancers and can guide preventive strategies and treatment decisions.
